Sutro Biopharma, Inc. (NASDAQ:STRO)
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $45.7M
- Net income
- -$180.6M
- Net margin
- -395.2%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $10.8M
- Cash
- $54.3M
Comfortably covers what is due within a year.
- Current assets
- $175.6M
- Current liabilities
- $52.9M
- Current ratio
- 3.32
Consumes cash and must keep raising it.
- Operating cash flow
- -$145.2M
- Free cash flow
- -$145.6M
- FCF margin
- -318.6%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 16.6M
- Share growth (1y)
- 95.9%
- Cash runway
- 4 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
STRO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.84 M | 14.52 M | 11.65 M | 9.69 M | 63.74 M | 17.40 M |
| Revenue Growth (YoY) | -84.57 % | -16.53 % | -21.35 % | 13.77 % | 147.98 % | 33.76 % |
| Cost of Revenue | 0.00 | 1.28 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 9.84 M | 13.24 M | 11.65 M | 9.69 M | 63.74 M | 17.40 M |
| SG&A Expense | 7.83 M | 7.58 M | 8.66 M | 8.74 M | 10.34 M | 13.27 M |
| R&D Expense | 31.70 M | 36.55 M | 36.64 M | 39.85 M | 38.33 M | 51.60 M |
| Operating Expenses | 39.73 M | 42.86 M | 45.30 M | 58.15 M | 67.09 M | 85.91 M |
| Operating Income | -29.89 M | -29.61 M | -33.66 M | -48.46 M | -3.35 M | -68.51 M |
| Pretax Income | -38.53 M | -38.50 M | -46.84 M | -56.86 M | -11.52 M | -75.97 M |
| Tax Provision | 1.00 K | -15.00 K | -82.00 K | 0.00 | -18.00 K | 0.00 |
| Net Income | -38.53 M | -38.48 M | -46.76 M | -56.86 M | -11.50 M | -75.97 M |
| EPS (Basic) | -2.33 | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 |
| EPS (Diluted) | -2.33 | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 |
| Shares Outstanding | 16.57 M | 13.08 M | 8.58 M | 8.49 M | 8.46 M | 8.31 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.